Σημειώσεις επεισοδίου
Welcome to Onco Life Centre Podcast. This episode explains a fast-track FDA approval of a PD-1 treatment for a small group of people with stage II or III rectal cancer. We look at who qualifies, what the trial found, and what is still unknown. You'll learn: - What the FDA approved on October 19, 2026 for stage II or III rectal cancer - Which tumors qualify and why a DNA mismatch repair test (dMMR or MSI-H) decides eligibility - How a PD-1 treatment helps the immune system find and kill canc...

